Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update.

Kevin McFarthing, Sue Buff,Gary Rafaloff,Brian Fiske,Leah Mursaleen,Rosie Fuest,Richard K Wyse,Simon R W Stott

Journal of Parkinson's disease（2023）

引用 3|浏览3

暂无评分

摘要

Our fourth annual review of active clinical trials evaluating ST and DMT therapeutics for PD demonstrates that the drug development pipeline is dynamic and evolving. The slow progress and lack of agents transitioning from Phase 2 to Phase 3 is concerning, but collective efforts by various stakeholders are being made to accelerate the clinical trial process, with the aim of bringing new therapies to the PD community sooner.

查看译文

关键词

Clinical trials, studies, Parkinson's, disease modification, neuroprotection, immunotherapy, inflammation, gene therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要